Analysts show increased negativity towards the business following recent results, reflected in a minor dip in next year's earnings per share predictions. Despite this, the unchanged consensus price target indicates that lower forecast earnings won't necessarily result in a future stock price drop. The company's revenue growth is expected to decelerate, with a projected annual decline of 3.9% by end of 2024, trailing the broader industry.

Deutsche Bank analysts suggest the company's statement on additional divestiture actions likely refers to a potential sale of its Pharma Solutions business. They see this as the most logical way for the company to meet its '24 net debt-to-EBITDA target of

Despite profitability, ongoing challenges may be shown in the share price decline in the past five years. Unfavorable market trends and warning signals associated with International Flavors & Fragrances could deter potential investors.